P1‐081: Optimization of the Pharmacokinetic (PK) and Pharmacodynamic (PD) Properties of an Anti‐Abeta Antibody M266 FAB Fragment Variant by Site‐Specific Pegylation. (1st July 2016) - Racke, Margaret M.; Day, Theresa A.; Hole, Justin T.; Chow, Chi-Kin; Lu, Jirong; DeMattos, Ronald B.